Patents by Inventor Renee Gardaix-Luthereau

Renee Gardaix-Luthereau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of providing anxiolytic and antipsychotic treatment
    Patent number: 5141949
    Abstract: Anxiolytic and antipsychotic treatment is provided to patients by administering therapeutically effective amounts of N-[2-(diethylamino)-ethyl]-2-methoxy-4-[(1-H-4,5-dihydro-2-imidazolyl)-ami no]-5-chlorobenzamide, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 31, 1991
    Date of Patent: August 25, 1992
    Assignee: Laboratoires Delagrange (Synthelabo)
    Inventors: Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Brenda Costall, Robert Naylor, Renee Gardaix-Luthereau
  • Method of increasing gastrointestinal motility with substituted benzamides
    Patent number: 5116857
    Abstract: The present invention relates to the use of substituted benzamides of formula (1): ##STR1## in which: A is linear or branched C.sub.1 -C.sub.3 alkyl; allyl or diethylaminoethyl;R.sub.1 is hydrogen or methyl, andZ-- is --NH--, --O-- or --S--,and of their pharmacologically acceptable salts for modifying gastric motility.
    Type: Grant
    Filed: December 14, 1989
    Date of Patent: May 26, 1992
    Assignee: Laboratoires Delagrange Div. Societe d'Applications Pharmacodynamiques
    Inventors: Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Brenda Costall, Robert Naylor, Renee Gardaix-Luthereau
  • Method of providing anxiolytic and antipsychotic treatment
    Patent number: 5116859
    Abstract: Anxiolytic and antipsychotic treatment is provided to patients by administering therapeutically effective amounts of N-[2-(diethylamino)-ethyl]-2-methoxy-4-[(1-H-4,5-dihydro-2-immidazolyl)-am ino]-5-chlorobenzamide, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 17, 1988
    Date of Patent: May 26, 1992
    Assignee: Laboratoires Delagrange Societe d'Application Pharmacodynamiques
    Inventors: Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Brenda Costall, Robert Naylor, Renee Gardaix-Luthereau
  • Method of treating disorders of cognitive function with substituted benzamides
    Patent number: 5110824
    Abstract: The invention relates to the use of benzamide derivatives of the formula: ##STR1## in which: A is a diethylaminoethyl group or a group of the formula II: ##STR2## where R is a C.sub.1 -C.sub.3 alkyl, allyl, cyclopropylmethyl or cyclohexenylmethyl group,X is a chlorine or bromine atom, andZ is --NH-- or --O-- with the following condition: when Z is --O--, A is a diethylaminoethyl group, and their pharmacologically acceptable salts for the preparation of medicinal products which are useful in the treatment and prevention of disorders of the cognitive function.
    Type: Grant
    Filed: April 12, 1990
    Date of Patent: May 5, 1992
    Assignee: Societe d'Etudes Scientifiques et Industrielles de L'Ile-de-France
    Inventors: Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Renee Gardaix-Luthereau, Brenda Costall, Robert Naylor
  • Method of providing anxiolytic and antipsychotic treatment with substituted benzamides
    Patent number: 5086066
    Abstract: The present invention relates to the application of substituted benzamides of formula (I): ##STR1## in which: A is diethylaminoethyl, 1-ethyl-2-pyrrolidinylmethyl or 1-allyl-2-pyrrolidinylmethyl;R.sub.1 is hydrogen or methyl;X is chlorine or bromine;Z is --NH-- or --O-- except when Z is --NH--,R.sub.1 is hydrogen and X is chlorine, and of their pharmacologically acceptable addition salts, as anxiolytics and antipsychotics.
    Type: Grant
    Filed: December 20, 1989
    Date of Patent: February 4, 1992
    Assignee: Laboratoires Delagrange Societe d'Applications Pharmacodnymiques
    Inventors: Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Renee Gardaix-Luthereau, Robert Naylor, Brenda Costall
  • Novel benzamides, intermediates and process for the preparation and therapeutic use thereof
    Patent number: 4835172
    Abstract: New substituted benzamides have the general formula: ##STR1## A=alkyl, alkenyl, diethylaminoethyl or ##STR2## R.sub.1, R.sub.2 =H, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl; R.sub.3, R.sub.4, R.sub.5, R.sub.6 =hydrogen or C.sub.1 -C.sub.6 alkyl;X=halogen;Y=H, halogen;Z=NH, oxygen or sulfur;their optical isomers and their physiologically acceptable salts. The compounds are used as activators of the central nervous system.
    Type: Grant
    Filed: December 19, 1986
    Date of Patent: May 30, 1989
    Assignee: Societe D'Etudes Scientifiques et Industrielles de L'Ile-de-France
    Inventors: Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Renee Gardaix-Luthereau, Brenda Costall, Robert Naylor
  • Benzamides and therapeutic use thereof
    Patent number: 4703055
    Abstract: The invention concerns novel benzamides and their pharmacologically acceptable salts which are useful as gastromotor agents and correspond to the following general formula (I): ##STR1## in which: R.sub.1 is lower alkyl, lower alkenyl or a hydrogen atom;R.sub.2 is alkyl, lower alkenyl, benzyl, cycloalkylalkyl, cycloalkenylalkyl or a hydrogen atom;R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7 and R.sub.8 each are lower alkyl or a hydrogen atom, andX is a halogen atom.
    Type: Grant
    Filed: July 7, 1986
    Date of Patent: October 27, 1987
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Jacqueline Franceschini, Renee Gardaix-Luthereau, Josette Margarit